New Strategies for the Conduct of Clinical Trials in Pediatric Pulmonary Arterial Hypertension: Outcome of a Multistakeholder Meeting With Patients, Academia, Industry, and Regulators, Held at the European Medicines Agency on Monday, June 12, 2017-Reference-Cited by-同舟云学术

New Strategies for the Conduct of Clinical Trials in Pediatric Pulmonary Arterial Hypertension: Outcome of a Multistakeholder Meeting With Patients, Academia, Industry, and Regulators, Held at the European Medicines Agency on Monday, June 12, 2017

Published:2019-05-21 Issue:10 Volume:8 Page:
ISSN:2047-9980
Container-title:Journal of the American Heart Association
language:en
Short-container-title:JAHA

Author:

Ollivier Cécile¹,Sun Haihao²,Amchin Wayne²,Beghetti Maurice³,Berger Rolf M. F.⁴,Breitenstein Stefanie⁵,Garnett Christine²,Gullberg Ninna¹,Hassel Patrik⁶,Ivy Dunbar⁷,Kawut Steven M.⁸,Klein Agnes⁹,Lesage Catherine¹⁰,Migdal Marek¹¹,Nije Barbara⁹,Odermarsky Michal¹²,Strait James¹³,de Graeff Pieter A.¹⁴,Stockbridge Norman²

Affiliation:

1. European Medicines Agency London United Kingdom

2. Food and Drug Administration Silver Spring MD

3. Pediatric Cardiology Unit Centre Universitaire de Cardiologie et Chirurgie Cardiaque Pédiatrique University Hospitals of Geneva City of Geneva Switzerland

4. Center for Congenital Heart Diseases Department of Pediatric Cardiology Beatrix Children's Hospital University Medical Center Groningen University of Groningen the Netherlands

5. Bayer AG, Pharmaceuticals, Research and Development Wuppertal Germany

6. PH Sweden Göteborg Sweden

7. Heart Institute Children's Hospital Colorado University of Colorado School of Medicine Aurora CO

8. Perelman School of Medicine University of Pennsylvania Philadelphia PA

9. Health Canada Ottawa Ontario Canada

10. Actelion Pharmaceuticals Ltd Allscwil Switzerland

11. Childrens Memorial Health Institute Warsaw Poland

12. Department of Paediatric Cardiology Paediatric Heart Center Lund University and Skåne University Hospital Lund Sweden

13. MSD Lucerne Switzerland

14. Medicines Evaluation Board Utrecht the Netherlands

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Link

https://www.ahajournals.org/doi/pdf/10.1161/JAHA.118.011306

Reference49 articles.

1. Paediatric drug use with focus on off‐label prescriptions at Swedish hospitals – a nationwide study

2. Off-Label Use of Drugs in Children

3. Pediatric Information in Drug Product Labeling

4. European Medicines Agency . Paroxetine. Resource [internet] EMA website 2004. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Paroxetine/human_referral_000131.jsp. Accessed February 14 2019.

5. Steps towards harmonization for clinical development of medicines in pediatric ulcerative colitis‐a global scientific discussion part 1: efficacy endpoints and disease outcome assessments;Sun H;J Pediatr Gastroenterol Nutr,2014

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Age- and Sex-Specific Reference Percentile Curves for Accelerometry-Measured Physical Activity in Healthy European Children;2024-09-03

2. The evolution of clinical trials for pediatric pulmonary hypertension: are the needs of patients and their caregivers being met?;Expert Review of Clinical Pharmacology;2024-09

3. Learning from conect4children: A Collaborative Approach towards Standardisation of Disease-Specific Paediatric Research Data;Data;2024-04-08

4. Selexipag for the Treatment of Pediatric Pulmonary Hypertension: A Systematic Review;Clinical Therapeutics;2024-01

5. Regulatory considerations in the design and conduct of pediatric clinical trials;Essentials of Translational Pediatric Drug Development;2024